Drug repurposing of glucosamine to ameliorate alcoholic liver disease and delay liver aging through activation of AMPK signaling pathway.
- DOI
- 10.1016/j.ejphar.2026.179143
- Published
- 2026 Jul 15
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179143,
title = {Drug repurposing of glucosamine to ameliorate alcoholic liver disease and delay liver aging through activation of AMPK signaling pathway.},
author = {Song Y and Li W and Shao Q and Huang J and Guo X and Wang X and Gu C and Ke J and Zhu T and Gao X and Liu W and Wang M and Li J and Xu Y and Li X},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179143},
url = {https://doi.org/10.1016/j.ejphar.2026.179143}
}RIS
TY - JOUR TI - Drug repurposing of glucosamine to ameliorate alcoholic liver disease and delay liver aging through activation of AMPK signaling pathway. AU - Song Y AU - Li W AU - Shao Q AU - Huang J AU - Guo X AU - Wang X AU - Gu C AU - Ke J AU - Zhu T AU - Gao X AU - Liu W AU - Wang M AU - Li J AU - Xu Y AU - Li X PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179143 UR - https://doi.org/10.1016/j.ejphar.2026.179143 ER -
APA
Y, S., W, L., Q, S., J, H., X, G., X, W., C, G., J, K., T, Z., X, G., W, L., M, W., J, L., Y, X., & X, L. (2026). Drug repurposing of glucosamine to ameliorate alcoholic liver disease and delay liver aging through activation of AMPK signaling pathway.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179143
Source records
- pubmed · retrieved 2026-09-25T10:55:26.703Z